No, the title does not mean that conventional sunscreen lotion should be swallowed!
This article discusses the science of oral photoprotection and the Indian reality….
The Article in 30 Seconds
The Claim: Oral photoprotective supplements promise protection against sunlight, tanning and pigmentation.
The Evidence: Some increase resistance to UV-induced redness, but convincing evidence for preventing tanning, DNA damage or skin cancer is lacking.
The Bottom Line: At approximately ₹37 a day, I would not routinely prescribe them for healthy Indian patients. Selected photosensitivity disorders may justify an adjunctive trial, although the evidence remains limited.
In Part 4 of this series I discussed how the most effective sunscreen may be a piece of cloth!
Now comes a rather convenient alternative: Swallow a capsule. No white cast. No greasy face. No reapplication. Just a fern extract, or perhaps some rosemary and grapefruit, with breakfast.
The photon still arrives
Conventional sunscreens reduce the amount of ultraviolet radiation reaching the skin. Oral photoprotective supplements do not. Ingredients such as Polypodium leucotomos, carotenoids and botanical polyphenols may modify the skin’s inflammatory and oxidative responses after UV exposure.
That is a plausible biological effect, and human research supports it to a degree. A 2025 systematic review identified 47 studies of oral photoprotective supplements. The authors found encouraging signals, particularly for Polypodium leucotomos and certain antioxidants, but repeatedly encountered small samples, short treatment periods and heterogeneous formulations.
“Oral photoprotection does have an effect. But whether it actually helps patients is another question.”
Less redness is not necessarily more protection
Researchers frequently assess oral photoprotection using the minimal erythema dose (MED): the amount of ultraviolet radiation required to produce visible redness.
In a 2025 placebo-controlled trial involving 54 fair-skinned volunteers, eight weeks of a supplement containing Polypodium leucotomos, red-orange extract and vitamins increased MED by 23.8%. That sounds promising.
But the same trial found no significant reduction in UV-induced pigmentation compared with placebo.
Recent experiments with Polypodium-containing preparations have also reported increases of approximately 26–29% in UVA or UVB erythema thresholds.
There is another complication. Despite improved erythema resistance, these studies did not demonstrate a significant reduction in UV-induced thymidine dimers, a specific measure of DNA photodamage, in the skin or urine.
This does not exclude other biological benefits. It does establish that reduced redness cannot automatically be interpreted as reduced DNA injury. Nor can these MED improvements be converted into an SPF rating.
Making skin harder to redden is not the same as proving that sunlight has become harmless.
The Indian question: will it prevent tanning?
This is where oral photoprotection encounters its biggest practical problem. In India, patients commonly seek sun protection to prevent tanning, melasma and worsening pigmentation, rather than sunburn. Yet much of the evidence comes from fair-skinned volunteers and studies measuring erythema rather than pigmentation.
The 2025 placebo-controlled trial is particularly revealing: less redness, but no demonstrated improvement in tanning.
A small Asian melasma study suggested some additional benefit from Polypodium, but every participant also received 4% hydroquinone and SPF 50+ sunscreen. Another placebo-controlled melasma trial did not establish a significant benefit.
These studies do not justify prescribing oral photoprotection routinely for pigmentation.
What about rosemary and grapefruit combinations marketed in India? The GO-REAL study reported favourable experiences in 850 patients across 85 centres. Impressive numbers, until we examine the design: a retrospective observational study without a placebo or untreated comparison group.
Patient and physician satisfaction cannot establish that the supplement prevented tanning or photodamage, especially when other treatments were being used. A large uncontrolled study is still an uncontrolled study.
What about skin cancer prevention?
Skin cancer incidence is substantially lower in India than in many Western fair-skinned populations, although it is certainly not nonexistent. That makes routine supplementation for hypothetical cancer prevention an even less compelling proposition for the average Indian patient.
More importantly, there is no adequately powered clinical trial demonstrating that these botanical oral photoprotectants prevent skin cancer.
Is there any reasonable indication?
Possibly, For selected patients with polymorphic light eruption or troublesome pathological photosensitivity, an oral photoprotectant might be considered alongside clothing, shade, appropriate sunscreen and disease-specific treatment.
But even here, the evidence is relatively thin. Many studies are small or uncontrolled, and clinically meaningful outcomes have not been consistently demonstrated.
Short-term tolerability appears reasonably reassuring for some studied preparations. Long-term safety and effectiveness across the many marketed formulations are much less certain.
So I would regard these products as optional adjuncts, not standard prescriptions.
And then comes the cost
At an approximate MRP of ₹37 per day, the treatment costs: ₹1,110 for 30 days. Approximately ₹13,500 for a year.
That may not appear particularly expensive by modern skincare standards. But cost-effectiveness is not determined by price alone.
For ₹37 a day, what additional benefit is the patient actually purchasing?
If the objective is prevention of tanning, the evidence is unconvincing. If it is prevention of skin cancer, clinical-outcome evidence for these botanical supplements is absent. If it is relief from pathological photosensitivity, a benefit is possible but insufficiently established.
A statistically significant change in UV tolerance does not automatically justify a clinically insignificant addition to the prescription.
My Verdict
For the average healthy Indian patient, I see no convincing justification for routinely prescribing oral photoprotective supplements, particularly for the prevention of tanning or pigmentation.
The relatively low incidence of skin cancer in India further weakens the case for routine cancer-prevention supplementation, especially without evidence that these products actually prevent cancer.
In selected patients with difficult photosensitivity or photodermatoses, I might consider an oral photoprotectant as an adjunct, with clear counselling that the evidence remains limited.
But at ₹37 a day, I would still want a convincing reason to add it.
My prescribing principle is simple: not routinely for tanning, not for theoretical cancer prevention, and only selectively for pathological photosensitivity.
The capsule may have a place beside your sunscreen. It has not earned the right to replace it.
And whatever you decide to swallow, don’t swallow the marketing.
References and Further Reading
Natarelli N, et al. Oral Supplements and Photoprotection: A Systematic Review. Journal of Medicinal Food. 2025;28:519–541. DOI: 10.1089/jmf.2024.0023
Keršmanc P, et al. Effects of Eight-Week Supplementation Containing Red Orange and Polypodium leucotomos Extracts on UVB-Induced Skin Responses. Nutrients. 2025;17:1240. DOI: 10.3390/nu17071240
Faisal A, et al. Changes in Ultraviolet A Radiation-Induced Thymidine Dimers and Erythema After Oral Nicotinamide or Polypodium leucotomos Extract. Photochemical & Photobiological Sciences. 2026;25:845–852. DOI: 10.1007/s43630-026-00884-2
Faisal A, et al. Changes in Ultraviolet B Radiation-Induced DNA Damage and Erythema After Oral Nicotinamide and Polypodium leucotomos. Photochemical & Photobiological Sciences. 2025;24:1951–1958. DOI: 10.1007/s43630-025-00807-7
Goh CL, et al. Double-blind, Placebo-controlled Trial to Evaluate the Effectiveness of Polypodium leucotomos Extract in the Treatment of Melasma in Asian Skin. Journal of Clinical and Aesthetic Dermatology. 2018;11:14–19. PubMed
Ahmed AM, et al. A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral Polypodium leucotomos Extract as an Adjunct to Sunscreen in the Treatment of Melasma. JAMA Dermatology. 2013. Read study
GO-REAL investigators. Real-World Evaluation of Antioxidant Properties of Grapefruit and Rosemary Combination Against Light-Induced Damage in Indian Population. Journal of Dermatology Research. 2025. Read study
Incidence of Melanoma and Nonmelanoma Skin Cancers in Indian and Global Regions. Journal of Cancer Research and Therapeutics. PubMed